Creatinyl amino acids: new hybrid compounds with neuroprotective activity.

Published on Sep 1, 2011in Journal of Peptide Science1.877
· DOI :10.1002/PSC.1379
Sergey V. Burov11
Estimated H-index: 11
Maria Leko7
Estimated H-index: 7
+ 2 AuthorsVeselkina Os2
Estimated H-index: 2
Prolonged oral creatine administration resulted in remarkable neuroprotection in experimental models of brain stroke. However, because of its polar nature creatine has poor ability to penetrate the blood–brain barrier (BBB) without specific creatine transporter (CRT). Thus, synthesis of hydrophobic derivatives capable of crossing the BBB by alternative pathway is of great importance for the treatment of acute and chronic neurological diseases including stroke, traumatic brain injury and hereditary CRT deficiency. Here we describe synthesis of new hybrid compounds—creatinyl amino acids, their neuroprotective activity in vivo and stability to degradation in different media. The title compounds were synthesized by guanidinylation of corresponding sarcosyl peptides or direct creatine attachment using isobutyl chloroformate method. Addition of lipophilic counterion (p-toluenesulfonate) ensures efficient creatine dissolution in DMF with simultaneous protection of guanidino group towards intramolecular cyclization. It excludes the application of expensive guanidinylating reagents, permits to simplify synthetic procedure and adapt it to large-scale production. The biological activity of creatinyl amino acids was tested in vivo on ischemic stroke and NaNO2-induced hypoxia models. One of the most effective compounds—creatinyl-glycine ethyl ester increases life span of experimental animals more than two times in hypoxia model and has neuroprotective action in brain stroke model when applied both before and after ischemia. These data evidenced that creatinyl amino acids can represent promising candidates for the development of new drugs useful in stroke treatment. Copyright © 2011 European Peptide Society and John Wiley & Sons, Ltd.
📖 Papers frequently viewed together
19 Citations
27 Citations
142 Citations
Abstract Creatine ethyl ester was incubated at 37 °C in both water and phosphate-buffered saline and the diagnostic methylene resonances in the 1 H NMR spectrum were used to identify the resultant products. It was found that mild aqueous conditions result in the cyclization of creatine ethyl ester to provide inactive creatinine as the exclusive product, and this transformation becomes nearly instantaneous as the pH approaches 7.4. This study demonstrates that mild non-enzymatic conditions are su...
22 CitationsSource
There are a number of forms of creatine available that attempt to improve the solubility and permeability, with the anticipation this will result in an improved pharmacokinetic profile and ultimately an enhanced ergogenic response. Previous research has shown that the different salt forms can improve solubility resulting in slightly altered pharmacokinetic profiles, however specific data exploring the conversion of esterified derivatives to creatine is lacking. The purpose of this study was to e...
8 CitationsSource
#1Konstantin Prass (Charité)H-Index: 9
#1Konstantin Prass (Charité)H-Index: 16
Last. Josef Priller (Charité)H-Index: 71
view all 9 authors...
Stroke leads to energy failure and subsequent neuronal cell loss. Creatine and phosphocreatine constitute a cellular energy buffering and transport system, and dietary creatine supplementation was shown to protect neurons in several models of neurodegeneration. Although creatine has recently been found to reduce infarct size after cerebral ischemia in mice, the mechanisms of neuroprotection remained unclear. We provide evidence for augmented cerebral blood flow (CBF) after stroke in creatine-tre...
104 CitationsSource
#1Autumn M. Klein (Brigham and Women's Hospital)H-Index: 1
#2Robert J. Ferrante (BU: Boston University)H-Index: 90
Significant progress has been made in identifying neuroprotective agents and their translation to patients with neurological disorders. While the direct causative pathways of neurodegeneration remain unclear, they are under great clinical and experimental investigation. There are a number of interrelated pathogenic mechanisms triggering molecular events that lead to neuronal death. One putative mechanism reported to play a prominent role in the pathogenesis of neurological diseases is impaired e...
47 CitationsSource
#1Valery Andrushchenko (U of C: University of Calgary)H-Index: 23
#2Hans J. Vogel (U of C: University of Calgary)H-Index: 158
Last. Elmar J. Prenner (U of C: University of Calgary)H-Index: 27
view all 3 authors...
Trifluoroacetate (CF3COO−, or TFA) is almost always present in commercially synthesized peptides. Unfortunately, it has a strong infrared (IR) absorption band at 1673 cm−1, significantly overlapping or even completely obscuring the amide I band of a peptide. In such cases TFA must be removed from the solution in order to be able to use IR absorption spectroscopy for peptide secondary structure determination. The most convenient and widely used procedure involves peptide lyophilization from a 0.1...
89 CitationsSource
#1David L. Christie (University of Auckland)H-Index: 31
Creatine and phosphocreatine provide an intracellular, high-energy phosphate buffering system, essential to maintain ATP levels in tissues with high energy demands. A specific plasma membrane creatine transporter (CRT) is required for the cellular uptake of creatine. This transporter is related to the \UPgamma -aminobutyric acid (GAT) and norepinephrine (NET) transporters and is part of a large gene family of Na+- and Cl--dependent neurotransmitter transporters, now known as solute carrier famil...
60 CitationsSource
#1Gianluigi Lunardi (UniGe: University of Genoa)H-Index: 13
#1Gian Luigi LunardiH-Index: 2
Last. Maurizio BalestrinoH-Index: 25
view all 11 authors...
Hereditary creatine transporter deficiency causes brain damage, despite the brain having the enzymes to synthesize creatine. Such damage occurring despite an endogenous synthesis is not easily explained. This condition is incurable, because creatine may not be delivered to the brain without its transporter. Creatine-derived compounds that crossed the blood–brain barrier in a transporter-independent fashion would be useful in the therapy of hereditary creatine transporter deficiency, and possibly...
45 CitationsSource
#1Shan Zhu (Brigham and Women's Hospital)H-Index: 9
#2Mingwei LiH-Index: 13
Last. Robert M. Friedlander (Brigham and Women's Hospital)H-Index: 62
view all 11 authors...
Creatine mediates remarkable neuroprotection in experimental models of amyotrophic lateral sclerosis, Huntington9s disease, Parkinson9s disease, and traumatic brain injury. Because caspase-mediated pathways are shared functional mechanistic components in these diseases, as well as in ischemia, we evaluated the effect of creatine supplementation on an experimental stroke model. Oral creatine administration resulted in a remarkable reduction in ischemic brain infarction and neuroprotection after c...
114 CitationsSource
By enhancing the leaving group character of benzotriazole via electron-withdrawing substituents such as the 5-chloro or 6-nitro derivatives with the related N,N‘-di-tert-butoxycarbonyl-1H-benzotriazole-1-carboxamidines, highly efficient reagents are obtained for conversion of primary and secondary amines in solution and in solid phase to diprotected guanidines.
30 CitationsSource
#1Ludmila Belayev (UM: University of Miami)H-Index: 35
#2Raul Busto (UM: University of Miami)H-Index: 99
Last. Myron D. Ginsberg (UM: University of Miami)H-Index: 95
view all 5 authors...
Abstract The present study was conducted to validate a modified method of temporary focal cerebral ischemia in the mouse; neurobehavioral function and histopathological infarction were quantitated following various periods of middle cerebral artery occlusion (MCAo). Male C57BL/6 mice were anesthetized with 3% halothane in a mixture of 30%O2/70%N2O delivered by face mask and were subjected to 30- to 180-min of temporary middle cerebral artery occlusion (MCAo) by an intraluminal suture coated with...
126 CitationsSource
Cited By21
#1Elsa Ghirardini (UniPi: University of Pisa)
#2Francesco Calugi (National Research Council)H-Index: 1
Last. Laura Baroncelli (National Research Council)H-Index: 22
view all 9 authors...
Creatine (Cr) Transporter Deficiency (CTD) is an X-linked metabolic disorder, mostly caused by missense mutations in the SLC6A8 gene and presenting with intellectual disability, autistic behavior, and epilepsy. There is no effective treatment for CTD and patients need lifelong assistance. Thus, the research of novel intervention strategies is a major scientific challenge. Animal models are an excellent tool to dissect the disease pathogenetic mechanisms and drive the preclinical development of t...
#1Olga Begou (MHH: Hannover Medical School)H-Index: 8
#1Olga Begou (MHH: Hannover Medical School)
Last. Dimitrios Tsikas (MHH: Hannover Medical School)H-Index: 65
view all 4 authors...
In consideration of its relatively constant urinary excretion rate, creatinine (2-amino-1-methyl-5H-imidazol-4-one, MW 113.1) in urine is a useful endogenous biochemical parameter to correct the urinary excretion rate of numerous endogenous and exogenous substances. Reliable measurement of creatinine by gas chromatography (GC)-based methods requires derivatization of its amine and keto groups. Creatinine exists in equilibrium with its open form creatine (methylguanidoacetic acid, MW 131.1), whic...
#1V. O. Mourovets (RAS: Russian Academy of Sciences)
#2M. V. Lentsman (RAS: Russian Academy of Sciences)
Introduction. According to WHO data, stroke and its consequences rank second in mortality after coronary heart disease. Hundreds of clinical trials have yielded only one tool that can be used – intravenous administration of recombinant plasminogen activator, i.e. recanalization agent. The means for effective neuroprotection, despite the huge number of studies, remain not found. The aim of the work was in vivo study of neuroprotective effect of creatine amide (AC-PfA) on neurological and cognitiv...
#1Veronika Rackayova (EPFL: École Polytechnique Fédérale de Lausanne)H-Index: 6
#2Cristina Cudalbu (EPFL: École Polytechnique Fédérale de Lausanne)H-Index: 19
Last. Olivier Braissant (UNIL: University of Lausanne)H-Index: 35
view all 4 authors...
Abstract Creatine (Cr) is an important organic compound acting as intracellular high-energy phosphate shuttle and in energy storage. While located in most cells where it plays its main roles in energy metabolism and cytoprotection, Cr is highly concentrated in muscle and brain tissues, in which Cr also appears to act in osmoregulation and neurotransmission. This review discusses the basis of Cr metabolism, synthesis and transport within brain cells. The importance of Cr in brain function and the...
46 CitationsSource
#1Layane Hanna-El-Daher (UNIL: University of Lausanne)H-Index: 4
#2Olivier Braissant (UNIL: University of Lausanne)H-Index: 35
While it has long been thought that most of cerebral creatine is of peripheral origin, the last 20 years has provided evidence that the creatine synthetic pathway (AGAT and GAMT enzymes) is expressed in the brain together with the creatine transporter (SLC6A8). It has also been shown that SLC6A8 is expressed by microcapillary endothelial cells at the blood–brain barrier, but is absent from surrounding astrocytes, raising the concept that the blood–brain barrier has a limited permeability for per...
35 CitationsSource
Background We have recently shown neuroprotective activity of the creatine amides in the focal cerebral ischemia in rats on the 280 mg/kg administration. In the present study, neuroprotective properties of creatylglycine ethyl ester fumarate (CrGEt) in rats with focal cerebral ischemia were explored in a wide dosage range (30-280 mg/kg, intravenous and intragastric). Methods Focal cerebral ischemia was induced by the middle cerebral artery occlusion (MCAO). Results The CrGEt administration 30 mi...
5 CitationsSource
#1Shuai Qian (CUHK: The Chinese University of Hong Kong)H-Index: 14
#2Qianwen Wang (CUHK: The Chinese University of Hong Kong)H-Index: 6
Last. Zhong Zuo (CUHK: The Chinese University of Hong Kong)H-Index: 40
view all 3 authors...
Introduction: Recently, developing peptide-based drugs to treat CNS diseases has gained increasing attention in both academics and pharmaceutical industry. However, targeting delivery of peptides to brain is one of the most challenging problems faced in the treatment of CNS diseases.Areas covered: After explaining the brain barriers limiting the delivery of peptides, the current review focuses on summarizing the most promising approaches for the enhancement of peptide and brain uptake, including...
7 CitationsSource
#1Juan V. Alegre-Requena (University of Zaragoza)H-Index: 12
#2Eugenia Marqués-López (University of Zaragoza)H-Index: 21
Last. Raquel P. Herrera (University of Zaragoza)H-Index: 28
view all 3 authors...
In the past decade, guanidines have attracted attention as valuable hydrogen bond-based catalysts while they have long been considered as organic superbases with a broad scope of synthetic applicability. Their easy modification has also expanded their capacity to form complexes with a wide range of metal salts as effective metal scavengers. All these attractive aspects have promoted a huge growth in the field of organic synthesis involving guanidines and examples of such reactions have been coll...
6 CitationsSource
#1Meir Goldsmith (TAU: Tel Aviv University)H-Index: 15
#2Lilach Abramovitz (TAU: Tel Aviv University)H-Index: 10
Last. Dan Peer (Houston Methodist Hospital)H-Index: 52
view all 3 authors...
The treatment of neurodegenerative diseases remains a tremendous challenge due to the limited access of molecules across the blood–brain barrier, especially large molecules such as peptides and proteins. As a result, at most, a small percentage of a drug that is administered systemically will reach the central nervous system in its active form. Currently, research in the field focuses on developing safer and more effective approaches to deliver peptides and proteins into the central nervous syst...
58 CitationsSource
Last. David C. EvansH-Index: 1
view all 4 authors...
The hypermetabolic nature of post-traumatic brain injury (TBI) state makes adequate nutri‐ tional support critical. Maintenance of adequate nutritional intake has been shown to have a significant impact on outcomes after TBI. [1] While pre-injury and immediate post-injury malnutrition has been associated with lower survival after TBI, much remains to be learned about the role and optimization of nutritional support beyond the initial phases of recovery. One of the most rapidly evolving aspects o...
1 CitationsSource